Ignite Creation Date:
2024-05-05 @ 5:02 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00375596
Status:
WITHDRAWN
Last Update Posted:
2015-02-20
First Post:
2006-09-12
Brief Title:
A Study Of The Safety And Effectiveness Of A New Treatment For Allergic Conjunctivitis
Sponsor:
Bausch Lomb Incorporated
Organization:
Bausch Lomb Incorporated
Study Overview
Official Title:
Study Withdrawn Prior to Determining Official Title
Status:
WITHDRAWN
Status Verified Date:
2015-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Study withdrawn without starting or enrolling subjects due to a business decision to not proceed with the project
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will evaluate the safety and efficacy of a new allergy medication
Detailed Description:
Study withdrawn prior to determining study details
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None